Table of Content

1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations

2. Executive Summary
2.1. Market Size & Estimates
2.2. Market Overview

3. Market Dynamics
3.1. Market Definition
3.2. Key Drivers
3.2.1. Widespread Acceptance Of Immunoglobulin-Based Therapies
3.2.2. Growing Usage Of Albumin In Other Therapeutic Areas
3.2.3. Growing Geriatric Population
3.2.4. Rising Prevalence Of Alpha-1 Antitrypsin Deficiency (Aatd)
3.2.5. Increase In The Patient Pool For Hemophilia Treatment
3.3. Key Restraints
3.3.1. Increasing Usage Of Recombinant Plasma Products In Therapeutic Treatments
3.3.2. High Costs Of Blood Plasma Treatments
3.3.3. Adverse Reactions Associated With Post-Transfusion
3.3.4. Spread Of Pathogenic Contaminants
3.3.5. High Regulations In The Market

4. Key Analytics
4.1. Porter’S Five Forces Analysis
4.1.1. Threat Of New Entry
4.1.2. Threat Of Substitution
4.1.3. Buyer’S Power
4.1.4. Supplier’S Power
4.1.5. Competitive Rivalry
4.2. Plasma Therapeutics Regulation
4.3. Clinical Guidelines
4.4. Opportunity Matrix
4.5. Vendor Landscape
4.6. Key Investment Insights

5. Market By Mode Of Delivery
5.1. Infusion Solutions
5.2. Gels
5.3. Sprays
5.4. Biomedical Sealants

6. Market By Disorder
6.1. Immunodeficiency Disease
6.2. Hypogammaglobulinemia
6.3. Hemophilia
6.4. Von Willebrand Disease (Vwd)
6.5. Other Disorders

7. Market By Blood Plasma Derivatives
7.1. Immunoglobulin
7.1.1. Intravenous Immunoglobulin
7.1.2. Subcutaneous Immunoglobulin
7.1.3. Other Immunoglobulin Types
7.2. Albumin
7.3. Hyperimmune
7.4. Coagulation Factor Concentrates
7.5. Other Plasma Fractionation Products

8. Market By Therapeutic Indication
8.1. Neurology
8.2. Immunology
8.3. Oncology
8.4. Transplantation
8.5. Hematology
8.6. Rheumatology
8.7. Pulmonology
8.8. Other Therapeutic Indication

9. Market By End-User
9.1. Hospitals And Clinics
9.2. Research Laboratories
9.3. Academic Institutions

10. Geographical Analysis
10.1. North America
10.1.1. The United States
10.1.2. Canada

11. Company Profiles
11.1. Adma Biologics
11.2. Arthrex
11.3. Bio Products Laboratory
11.4. Baxter International
11.5. Biotest Ag
11.6. Cerus Corporation (Cerus)
11.7. China Biologic Products
11.8. Csl Limited
11.9. Fusion Health Care
11.10. Green Cross Holdings Corporation
11.11. Grifols
11.12. Lfb
11.13. Octapharma
11.14. Takeda Pharmaceutical Company
11.15. Kedrion Biopharma Inc



List of Figures


Figure 1: Porter’S Five Force Analysis
Figure 2: Opportunity Matrix
Figure 3: Vendor Landscape
Figure 4: Key Investment Insights
Figure 5: Immunoglobulin Infusions Side Effects
Figure 6: Role Of Fibrin Sealant In Coagulation Cascade
Figure 7: North America Blood Plasma Market, By Disorder, In 2019
Figure 8: North America Blood Plasma Market, By Immunodeficiency Disease, 2020-2028 (In $ Million)
Figure 9: North America Blood Plasma Market, By Hypogammaglobulinemia, 2020-2028 (In $ Million)
Figure 10: North America Blood Plasma Market, By Hemophilia, 2020-2028 (In $ Million)
Figure 11: North America Blood Plasma Market, By Von Willebrand Disease (Vwd), 2020-2028 (In $ Million)
Figure 12: North America Blood Plasma Market, By Other Disorders, 2020-2028 (In $ Million)
Figure 13: North America Blood Plasma Market, By Blood Derivatives, In 2019
Figure 14: North America Blood Plasma Market, By Immunoglobulin, 2020-2028 (In $ Million)
Figure 15: North America Immunoglobulin Market, By Intravenous Immunoglobulin, 2020-2028 (In $ Million)
Figure 16: North America Immunoglobulin Market, By Subcutaneous Immunoglobulin, 2020-2028 (In $ Million)
Figure 17: North America Immunoglobulin Market, By Other Immunoglobulin Types, 2020-2028 (In $ Million)
Figure 18: North America Blood Plasma Market, By Albumin, 2020-2028 (In $ Million)
Figure 19: North America Blood Plasma Market, By Hyperimmune, 2020-2028 (In $ Million)
Figure 20: Hyperimmunes Isolation Process
Figure 21: North America Blood Plasma Market, By Coagulation Factor Concentrates, 2020-2028 (In $ Million)
Figure 22: North America Blood Plasma Market, By Other Plasma Fractionation Products, 2020-2028 (In $ Million)
Figure 23: North America Blood Plasma Market, By Therapeutic Indication, In 2019
Figure 24: North America Blood Plasma Market, By Neurology, 2020-2028 (In $ Million)
Figure 25: North America Blood Plasma Market, By Immunology, 2020-2028 (In $ Million)
Figure 26: North America Blood Plasma Market, By Oncology, 2020-2028 (In $ Million)
Figure 27: North America Blood Plasma Market, By Transplantation, 2020-2028 (In $ Million)
Figure 28: North America Blood Plasma Market, By Hematology, 2020-2028 (In $ Million)
Figure 29: North America Blood Plasma Market, By Rheumatology, 2020-2028 (In $ Million)
Figure 30: Lupus Infection Symptoms
Figure 31: North America Blood Plasma Market, By Pulmonology, 2020-2028 (In $ Million)
Figure 32: North America Blood Plasma Market, By Other Therapeutic Indication, 2020-2028 (In $ Million)
Figure 33: North America Blood Plasma Market, By End-User, In 2019
Figure 34: North America Blood Plasma Market, By Hospitals And Clinics, 2020-2028 (In $ Million)
Figure 35: North America Blood Plasma Market, By Research Laboratories, 2020-2028 (In $ Million)
Figure 36: North America Blood Plasma Market, By Academic Institutions, 2020-2028 (In $ Million)
Figure 37: North America Blood Plasma Market, Country Outlook, 2019 & 2028 (In %)
Figure 38: The United States Blood Plasma Market, 2020-2028 (In $ Million)
Figure 39: Canada Blood Plasma Market, 2020-2028 (In $ Million)


List of Tables


List of Tables


TABLE 1: MARKET SNAPSHOT - BLOOD PLASMA
TABLE 2: NORTH AMERICA BLOOD PLASMA MARKET, BY DISORDER, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 3: NORTH AMERICA BLOOD PLASMA MARKET, BY DISORDER, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 4: NORTH AMERICA BLOOD PLASMA MARKET, BY BLOOD DERIVATIVES, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 5: NORTH AMERICA BLOOD PLASMA MARKET, BY BLOOD DERIVATIVES, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 6: NORTH AMERICA BLOOD PLASMA MARKET, BY THERAPEUTIC INDICATION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 7: NORTH AMERICA BLOOD PLASMA MARKET, BY THERAPEUTIC INDICATION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 8: NORTH AMERICA BLOOD PLASMA MARKET, BY END-USER, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 9: NORTH AMERICA BLOOD PLASMA MARKET, BY END-USER, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 10: NORTH AMERICA BLOOD PLASMA, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 11: NORTH AMERICA BLOOD PLASMA, BY COUNTRY, FORECAST YEARS, 2020-2028 (IN $ MILLION)